Blood pressure control in type 2 diabetes mellitus

American Journal of Kidney Diseases

Volumn 56, Issue 6, 2010, Pages 1029-1031

  Chang, Tara I ^a   Cheung, Alfred K ^b   Chertow, Glenn M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; PLACEBO; SIMVASTATIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DEMENTIA; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; HYPERTENSION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; SYSTOLIC BLOOD PRESSURE;

EID: 78649451423     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.08.007     Document Type: Editorial

References (14)

1. World Health Organization Diabetes Programme, Facts and Figures http://www.who.int/diabetes/facts/world-figures/en/ Accessed May 20, 2010
2. National diabetes statistics 2007 http://diabetes.niddk.nih.gov/dm/pubs/ statistics/index.htm Accessed May 20, 2010
3. L. Hansson, A. Zanchetti, and S.G. Carruthers Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 9118 1998 1755 1762 (Pubitemid 28269185)
4. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 7160 1998 703 713
5. A. Patel ADVANCE Collaborative Group Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 9590 2007 829 840
6. A.V. Chobanian, G.L. Bakris, and H.R. Black National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 19 2003 2560 2572
7. R.O. Estacio, B.W. Jeffers, W.R. Hiatt, S.L. Biggerstaff, N. Gifford, and R.W. Schrier The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension N Engl J Med 338 10 1998 645 652
8. R.G. Dluhy, and G.T. McMahon Intensive glycemic control in the ACCORD and ADVANCE trials N Engl J Med 358 24 2008 2630 2633
9. ACCORD Study Group Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 17 2010 1563 1574
10. ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 17 2010 1575 1585
11. S. Shastri, and M.J. Sarnak Blood pressure target in individuals without diabetes: what is the evidence? Am J Kidney Dis 56 3 2010 434 438
12. R.O. Estacio, B.W. Jeffers, N. Gifford, and R.W. Schrier Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes Diabetes Care 23 suppl 2 2000 B54 B64
13. National Kidney Foundation K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease 2004 http://www.kidney.org/professionals/KDOQI/guidelines-bp/index.htm Accessed May 25, 2010
14. National Institutes of Health NIH launches multicenter clinical trial to test blood pressure strategy http://www.nih.gov/news/health/oct2009/nhlbi-29.htm Accessed May 20, 2010